苏格兰1型糖尿病患者起始闪速监测与HbA1c水平及DKA发生率改善相关:一项回顾性全国观察性研究
该回顾性全国注册研究纳入2014年至2020年中使用闪速监测(FM)的14682例苏格兰1型糖尿病患者,评估FM对HbA1c、糖尿病酮症酸中毒(DKA)及严重住院低血糖(SHH)的影响。结果显示FM起始后HbA1c中位变化为-2.5 mmol/mol,基线HbA1c>84 mmol/mol者降幅达-15.5 mmol/mol,DKA事件率比为0.59,SHH高风险者事件率比为0.25。
要点
- FM起始后整体HbA1c中位下降2.5 mmol/mol,基线HbA1c越高降幅越大。
- FM起始后DKA事件率比为0.59,SHH高风险者事件率比为0.25。
- FM使用率在社会经济弱势群体中较低,提高其使用可能缩小血糖结局差异。
核心结论
- FM起始与HbA1c临床重要降低及DKA发生率显著下降相关。
- 增加社会经济弱势群体的FM使用可能有助于缩小血糖相关结局的社会经济差异。
研究设计与样本
- 回顾性、观察性、基于注册的研究,利用苏格兰全国糖尿病注册系统识别2014年至2020年中任何时点使用FM的14682例1型糖尿病患者。
- 采用线性混合模型分析FM起始后HbA1c的个体内变化,并考虑暴露前轨迹;通过链接住院和死亡数据捕获DKA和SHH事件。
- 使用广义线性混合模型(泊松似然)评估FM暴露与未暴露人时之间DKA和SHH率的差异,并进行敏感性分析。
主要发现
- 截至2020年中,曾使用FM的患病率为45.9%,年龄<13岁儿童为64.3%,≥65岁者为32.7%;最不贫困五分位为54.4%,最贫困五分位为36.2%。
- FM起始后一年内HbA1c中位(IQR)个体内变化为-2.5(-9.0, 2.5)mmol/mol(-0.2 [-0.8, 0.2]%)。
- 基线HbA1c >84 mmol/mol(9.8%)者HbA1c变化为-15.5(-31.0, -4.0)mmol/mol(-1.4 [-2.8, -0.4]%),估计倍数变化为0.77(95%CI 0.76, 0.78)。
- 基线HbA1c <54 mmol/mol(7.1%)者HbA1c变化为1.0(-2.0, 5.5)mmol/mol(0.1 [-0.2, 0.5]%),估计倍数变化为1.08(95%CI 1.07, 1.09)。
- 匹配的非使用者同期HbA1c中位(IQR)个体内变化为0.5(-5.0, 5.5)mmol/mol(0.0 [-0.5, 0.5]%)。
临床怎么用
- 对于1型糖尿病患者,起始FM可能改善血糖控制并降低DKA风险,尤其基线HbA1c较高者获益更明显。
- 应关注社会经济弱势群体和青少年,提高FM使用率以缩小差异并优化结局。
局限性
- 本研究为回顾性观察性设计,可能存在残余混杂。
- DKA和SHH事件通过住院和死亡数据链接捕获,可能存在漏报或错分。
- 青少年亚组中未观察到DKA率降低,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We assessed the real-world effect of flash monitor (FM) usage on HbA1c levels and diabetic ketoacidosis (DKA) and severe hospitalised hypoglycaemia (SHH) rates among people with type 1 diabetes in Scotland and across sociodemographic strata within this population. METHODS: This study was retrospective, observational and registry based. Using the national diabetes registry, 14,682 individuals using an FM at any point between 2014 and mid-2020 were identified. Within-person change from baseline in HbA1c following FM initiation was modelled using linear mixed models accounting for within-person pre-exposure trajectory. DKA and SHH events were captured through linkage to hospital admission and mortality data. The difference in DKA and SHH rates between FM-exposed and -unexposed person-time was assessed among users, using generalised linear mixed models with a Poisson likelihood. In a sensitivity analysis, we tested whether changes in these outcomes were seen in an age-, sex- and baseline HbA1c-matched sample of non-users over the same time period. RESULTS: Prevalence of ever-FM use was 45.9% by mid-2020, with large variations by age and socioeconomic status: 64.3% among children aged <13 years vs 32.7% among those aged ≥65 years; and 54.4% vs 36.2% in the least-deprived vs most-deprived quintile. Overall, the median (IQR) within-person change in HbA1c in the year following FM initiation was -2.5 (-9.0, 2.5) mmol/mol (-0.2 [-0.8, 0.2]%). The change varied widely by pre-usage HbA1c: -15.5 (-31.0, -4.0) mmol/mol (-1.4 [-2.8, -0.4]%) in those with HbA1c > 84 mmol/mol [9.8%] and 1.0 (-2.0, 5.5) mmol/mol (0.1 [-0.2, 0.5]%) in those with HbA1c < 54 mmol/mol (7.1%); the corresponding estimated fold change (95% CI) was 0.77 (0.76, 0.78) and 1.08 (1.07, 1.09). Significant reductions in HbA1c were found in all age bands, sexes and socioeconomic strata, and regardless of prior/current pump use, completion of a diabetes education programme or early FM adoption. Variation between the strata of these factors beyond that driven by differing HbA1c at baseline was slight. No change in HbA1c in matched non-users was observed in the same time period (median [IQR] within-person change = 0.5 [-5.0, 5.5] mmol/mol [0.0 (-0.5, 0.5)%]). DKA rates decreased after FM initiation overall and in all strata apart from the adolescents. Estimated overall reduction in DKA event rates (rate ratio) was 0.59 [95% credible interval (CrI) 0.53, 0.64]) after FM vs before FM initiation, accounting for pre-exposure trend. Finally, among those at higher risk for SHH, estimated reduction in event rates was rate ratio 0.25 (95%CrI 0.20, 0.32) after FM vs before FM initiation. CONCLUSIONS/INTERPRETATION: FM initiation is associated with clinically important reductions in HbA1c and striking reduction in DKA rate. Increasing uptake among the socioeconomically disadvantaged offers considerable potential for tightening the current socioeconomic disparities in glycaemia-related outcomes.
引用
- Jeyam A, Gibb FW, McKnight JA, et al. Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study. Diabetologia. 2021. PMID: 34618177. doi:10.1007/s00125-021-05578-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。